Remedor Biomed, Ltd.
Remedor Biomed is a clinical research stage biopharmaceutical company focused on revolutionizing complex wound treatment through patented technology. The company aims to provide innovative solutions for diabetic foot ulcers and complex skin wound conditions, significantly impacting patients' lives and healthcare systems.
Industries
Nr. of Employees
small (1-50)
Remedor Biomed, Ltd.
Patents
Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
US-12427182-B2
View DetailsTopical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
US-11213569-B2
View DetailsErythropoietin and fibronectin compositions for therapeutic and cosmetic applications
US-10792338-B2
View Details
Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
US-12427182-B2
View DetailsTopical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
US-11213569-B2
View DetailsErythropoietin and fibronectin compositions for therapeutic and cosmetic applications
US-10792338-B2
View DetailsProducts
Topical hydrogel-based wound therapy (lead product)
A topical biodegradable hydrogel-matrix product formulated with an approved biologic active ingredient to accelerate healing of chronic and acute skin wounds when applied directly to the wound bed; supplied in multi-use tubes for clinic or home use.
Topical hydrogel-based wound therapy (lead product)
A topical biodegradable hydrogel-matrix product formulated with an approved biologic active ingredient to accelerate healing of chronic and acute skin wounds when applied directly to the wound bed; supplied in multi-use tubes for clinic or home use.
Services
Design and conduct of clinical trials for topical wound therapeutics, including Phase 2 studies in patients with hard-to-heal ulcers.
Formulation development, stability optimization, manufacturing control coordination, and analytical testing management for topical hydrogel products containing biologic actives.
Design and conduct of clinical trials for topical wound therapeutics, including Phase 2 studies in patients with hard-to-heal ulcers.
Formulation development, stability optimization, manufacturing control coordination, and analytical testing management for topical hydrogel products containing biologic actives.
Expertise Areas
- Topical wound therapeutics development
- Clinical trial management for wound care
- Formulation and CMC for topical biologics
- Preclinical wound healing models
Key Technologies
- Topical hydrogel matrices
- Biologic active ingredient formulation
- Stability-enhanced topical formulations
- Topical delivery systems (multi-use tubes)